Natixis’s AdaptHealth AHCO Stock Holding History

Natixis’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.65M	Buy	350,000 +319,700	+1,055%	+$3.57M	0.01%	506
2026 Q1	$361K	Sell	30,300 -259,700	-90%	-$2.66M	﹤0.01%	858
2025 Q4	$2.89M	Buy	+290,000	New	+$2.77M	0.01%	554
2022 Q4	–	Sell	-94,000	Closed	-$1.76M	–	1078
2022 Q3	$1.76M	Sell	94,000 -26,000	-22%	-$534K	0.01%	634
2022 Q2	$2.17M	Buy	+120,000	New	+$1.95M	0.01%	648

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Natixis's AHCO Position: Q2 2026 in Review

Natixis increased its AdaptHealth (AHCO) stake by 1,055% in Q2 2026, buying an estimated $3.57M and bringing the position to 350,000 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #506.

Natixis first reported a position in AHCO in Q2 2022 and has held it in 5 quarters since. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

Natixis held 350,000 shares of AdaptHealth worth $3.65M as of Q2 2026.
Natixis bought 319,700 AdaptHealth shares in Q2 2026, an estimated $3.57M.
AdaptHealth made up 0.01% of Natixis's portfolio in Q2 2026, its #506 holding.
Natixis first reported a position in AdaptHealth in Q2 2022 and has held it in 5 quarters since.
239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.